BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 23981319)

  • 1. Treatment of refractory irritable bowel syndrome with visceral osteopathy: short-term and long-term results of a randomized trial.
    Attali TV; Bouchoucha M; Benamouzig R
    J Dig Dis; 2013 Dec; 14(12):654-61. PubMed ID: 23981319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?
    van Wanrooij SJ; Wouters MM; Van Oudenhove L; Vanbrabant W; Mondelaers S; Kollmann P; Kreutz F; Schemann M; Boeckxstaens GE
    Am J Gastroenterol; 2014 Jan; 109(1):99-109. PubMed ID: 24189713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome.
    Verne GN; Sen A; Price DD
    J Pain; 2005 Aug; 6(8):493-6. PubMed ID: 16084463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
    Caldarella MP; Milano A; Laterza F; Sacco F; Balatsinou C; Lapenna D; Pierdomenico SD; Cuccurullo F; Neri M
    Am J Gastroenterol; 2005 Feb; 100(2):383-9. PubMed ID: 15667496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review.
    Müller A; Franke H; Resch KL; Fryer G
    J Am Osteopath Assoc; 2014 Jun; 114(6):470-9. PubMed ID: 24917634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
    Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A; Csizmadia C; Illés A; Undi S
    Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome.
    Ng C; Malcolm A; Hansen R; Kellow JE
    Neurogastroenterol Motil; 2006 Mar; 18(3):206-10. PubMed ID: 16487411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral nerve stimulation changes rectal sensitivity and biomechanical properties in patients with irritable bowel syndrome.
    Fassov J; Brock C; Lundby L; Drewes AM; Gregersen H; Buntzen S; Laurberg S; Krogh K
    Neurogastroenterol Motil; 2014 Nov; 26(11):1597-604. PubMed ID: 25223743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study.
    Elsenbruch S; Rosenberger C; Enck P; Forsting M; Schedlowski M; Gizewski ER
    Gut; 2010 Apr; 59(4):489-95. PubMed ID: 19651629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S; Mahayosnond A; Kullavanijaya P
    Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome.
    Vlieger AM; van den Berg MM; Menko-Frankenhuis C; Bongers ME; Tromp E; Benninga MA
    Am J Gastroenterol; 2010 Jan; 105(1):213-8. PubMed ID: 19861956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
    van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
    Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
    Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Kuiken SD; Lindeboom R; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Jul; 22(2):157-64. PubMed ID: 16011674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.